Nvidia’s results, Indian tariffs, French markets - what’s moving markets
Investing.com -- Envista Holdings Corporation (NYSE:NVST) shares surged 8.3% after the company reported second-quarter earnings that exceeded analyst expectations and raised its full-year outlook, driven by accelerated growth across all business segments and major geographies.
The dental products company reported adjusted earnings per share of $0.26 for the quarter ended June 27, 2025, beating analyst estimates of $0.23. Revenue came in at $682 million, significantly above the consensus estimate of $639.99 million, with core sales growth of 5.6% YoY.
"Envista achieved accelerated growth across all of our businesses and major geographies in the second quarter," said Paul Keel, CEO. "This allowed us to further increase investments in growth, operations, and people, while also delivering strong improvement in year-over-year profitability."
The company’s adjusted EBITDA rose 34% YoY to $84 million, with adjusted EBITDA margin expanding 240 basis points to 12.4%. Notably, all major businesses and geographies delivered positive growth, including Nobel Biocare in North America.
For the first half of 2025, Envista reported sales of $1.29 billion with core sales growth of 2.9% compared to the same period in 2024. First-half adjusted EPS reached $0.50, up 35% YoY.
Based on its strong performance, Envista raised its full-year 2025 guidance, now expecting core sales growth of 3% to 4%, up from the previous forecast of 1% to 3%. The company also increased its adjusted EPS outlook to $1.05-$1.15, above the analyst consensus of $1.02.
During the quarter, Envista repurchased 4.8 million shares for approximately $82 million, with $150 million remaining under its stock repurchase program at quarter-end.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.